Correction to: Clinical characteristics of the ALK fusion-positive bladder PMP and efficacy of lorlatinib: a two-case report and literature review
Fields of Study & Subjects
Lung Cancer Treatments and Mutations
Bladder and Urothelial Cancer Treatments
Sarcoma Diagnosis and Treatment
Publication details
- Journal / source
- The Oncologist
- Volume
- 31
- Issue
- 3
- Publication date
- 5 February 2026
- Language
- EN